Vyera claims Qualcomm reversal supports its defence against FTC
Vyera Pharmaceuticals has said a federal appellate court’s recent Qualcomm decision supports the company’s defence against FTC claims that it violated antitrust laws.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10